000			02003 a2200565 4500
005			20250515221712.0
264		0	_c20101021
008			201010s 0 0 eng d
022			_a1935-5548
024	7		_a10.2337/dc09-2241 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlkhalaf, Alaa
245	0	0	_aA double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. _h[electronic resource]
260			_bDiabetes care _cJul 2010
300			_a1598-601 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlbuminuria _xdrug therapy
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aBiomarkers _xurine
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDiabetic Nephropathies _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepatitis A Virus Cellular Receptor 1
650	0	4	_aHumans
650	0	4	_aKidney Tubules _xdrug effects
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins _xurine
650	0	4	_aMiddle Aged
650	0	4	_aPlacebos
650	0	4	_aReceptors, Virus
650	0	4	_aThiamine _xadministration & dosage
700	1		_aKlooster, Astrid
700	1		_avan Oeveren, Willem
700	1		_aAchenbach, Ulrike
700	1		_aKleefstra, Nanne
700	1		_aSlingerland, Robbert J
700	1		_aMijnhout, G Sophie
700	1		_aBilo, Henk J G
700	1		_aGans, Reinold O B
700	1		_aNavis, Gerjan J
700	1		_aBakker, Stephan J L
773	0		_tDiabetes care _gvol. 33 _gno. 7 _gp. 1598-601
856	4	0	_uhttps://doi.org/10.2337/dc09-2241 _zAvailable from publisher's website
999			_c19771025 _d19771025